Andersen, B.L., Carpenter, K.M., Yang, H., & Shapiro, C.L. (2007). Sexual well-being among partnered women with breast cancer recurrence. Journal of Clinical Oncology, 25(21), 3151-3157.
Avis, N.E., Crawford, S., & Manuel, J. (2005). Quality of life among younger women with breast cancer. Journal of Clinical Oncology, 23(15), 3322-3330.
Ballagh, S.A. (2005). Vaginal hormone therapy for urogenital and menopausal symptoms. Seminars in Reproductive Medicine, 23(2), 126-140.
Barlow, D.H., Samsioe, G., & van Geelen, J.M. (1997). A study of European women's experience of the problems of urogenital aging and its management. Maturitas, 27(3), 239-247.
Barsevick, A.M. (2007). The elusive concept of the symptom cluster. Oncology Nursing Forum, 34(5), 971-979.
Barton, D., Wilwerding, M., Carpenter, L., & Loprinzi, C. (2004). Libido as part of sexuality in female cancer survivors. Oncology Nursing Forum, 31(3), 599-609.
Boekhout, A.H., Beijnen, J.H., & Schellens, J.H.M. (2006). Symptoms and treatment in cancer therapy-induced early menopause. Oncologist, 11(6), 641-654.
Carpenter, J.S., Elam, J.L., Ridner, S.H., Carney, P.H., Cherry, G.J., & Cucullu, H.L. (2004). Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncology Nursing Forum, 31(3), 591-598.
Del Mastro, L., Venturini, M., Sertoli, M.R., & Rosso, R. (1997). Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: Prognostic role and clinical implications. Breast Cancer Research and Treatment, 43(2), 183-190.
Ganz, P.A. (2005). Breast cancer, menopause, and long-term survivorship: Critical issues for the 21st century. American Journal of Medicine, 118(12B), 136S-141S.
Ganz, P.A., Desmond, K.A., Belin, T.R., Meyerowitz, B.E., & Rowland, J.H. (1999). Predictors of sexual health in women after a breast cancer diagnosis. Journal of Clinical Oncology, 17(8), 2371-2380.
Ganz, P.A., Greendale, G.A., Petersen, L., Kahn, B., & Bower, J.E. (2003). Breast cancer in younger women: Reproductive and late health effects of treatment. Journal of Clinical Oncology, 21(22), 4184-4193.
Ganz, P.A., Greendale, G.A., Petersen, L., Zibecchi, L., Kahn, B., & Belin, T.R. (2000). Managing menopausal symptoms in breast cancer survivors: Results of a randomized controlled trial. Journal of the National Cancer Institute, 92(13), 1054-1064.
Glaus, A., Boehme, C., Thurlimann, B., Ruhstaller, T., Hsu Schmitz, S.F., Moran, R., et al. (2006). Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Annals of Oncology, 17(5), 801-806.
Goodwin, P.J., Ennis, M., Pritchard, K.I., Trudeau, M., & Hood, N. (1999). Risk of menopause during the first year after breast cancer diagnosis. Journal of Clinical Oncology, 17(8), 2365-2370.
Gupta, P., Sturdee, D.W., Palin, S.L., Majumder, K., Fear, R., Marshall, T., et al. (2006). Menopausal symptoms in women treated for breast cancer: The prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric, 9(1), 49-58.
Henson, H. (2002). Breast cancer and sexuality. Sexuality and Disability, 20(4), 261-275.
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M.J. (2009). Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59(4), 225-249.
Johnston, S., & Farrell, S. (2004). The detection and management of vaginal atrophy. Journal SOGC, 145(5), 503-507.
Kelley, C. (2007). Estrogen and its effect on vaginal atrophy in postmenopausal women. Urologic Nursing, 27(1), 40-45.
Knobf, M.T. (1998). Natural menopause and ovarian toxicity associated with breast cancer therapy. Oncology Nursing Forum, 25(9), 1519-1530.
Knobf, M.T. (2006). Breast cancer: The influence of endocrine effects of adjuvant therapy on quality-of-life outcomes in younger breast cancer survivors. Oncologist, 11(2), 96-110.
Lee, M.K., Son, B.H., Hwang, S.Y., Han, W., Yang, J.H., Lee, S., et al. (2007). Factors affecting health-related quality of life in women with recurrent breast cancer in Korea. Quality of Life Research, 16(4), 559-569.
Lenz, E.R., & Pugh, L.C. (2003). The theory of unpleasant symptoms. In M.J. Smith & P. Liehr (Eds.), Middle range theory for nursing (pp. 69-90). New York: Springer.
McKenna, S.P., Whalley, D., Renck-Hooper, U., Carlin, S., & Doward, L.C. (1999). The development of quality-of-life instrument for use with postmenopausal women with urogenital atrophy in the United Kingdom and Sweden. Quality of Life Research, 8(5), 393-398.
Meyerowitz, B.E., Desmond, K.A., Rowland, J.H., Wyatt, G.E., & Ganz, P.A. (1999). Sexuality following breast cancer. Journal of Sex and Marital Therapy, 25(3), 237-250.
Morali, G., Poplatti, F., Metelitsa, E.N., Marcarucci, P., Magnani, P., & Marre, G.B. (2006). Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in the form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arznelm-Forsch Drug Research, 56(3), 230-238.
Oh, S., Heflin, L., Meyerowitz, B.E., Desmond, K.A., Rowland, J.H., & Ganz, P.A. (2004). QOL of breast cancer survivors after a recurrence: A follow-up study. Breast Cancer Research and Treatment, 87(1), 45-57.
Santoro, N. (2005). The menopause transition. American Journal of Medicine, 118(12B), 85-135.
Schover, L. (2008). Premature ovarian failure and its consequences: Vasomotor symptoms, sexuality, and fertility. Journal of Clinical Oncology, 26(5), 753-758.
Schultz, P.N., Klein, M.J., Beck, M.L., Stava, C., & Sellin, R.V. (2005). Breast cancer: Relationship between menopausal symptoms, physiologic health effects of cancer treatment, and physical constraints on quality of life in long-term survivors. Journal of Clinical Nursing, 14(2), 204-211.
Stricker, C.T. (2007). Endocrine effects of breast cancer treatment. Seminars in Oncology Nursing, 23(1), 55-70.
van Geelen, J.M., Van De Weijer, P.H., & Arnolds, H.T. (2000). Urogenital symptoms and resulting discomfort in noninstitutionalized Dutch women aged 50-75 years. International Urogynecology Journal and Pelvic Floor Dysfunction, 11(1), 9-14.
Willhite, L.A., & O'Connell, M.B. (2001). Urogenital atrophy: Prevention and treatment. Pharmacotherapy, 21(4), 464-480.
Woods, N.F., & Mitchell, E.S. (2005). Symptoms during the perimenopause: Prevalence, severity, trajectory, and significance in women's lives. American Journal of Medicine, 118(12B), 14S-24S.
Zibecchi, L., Greendale, G.A., & Ganz, P.A. (2003). Comprehensive menopausal assessment: An approach to managing vasomotor and urogenital symptoms in breast cancer survivors. Oncology Nursing Forum, 30(3), 393-407.